Clinical case of non-immune hydrops in a preterm infant with IgG to SARS-CoV-2 at birth

Non-immune hydrops of the fetus is a heterogeneous pathology, which is accompanied by excessive accumulation of fluid in two or more serous cavities (pericardial cavity, abdominal cavity, pleural cavity) and fetal tissues in the absence of signs of immune sensitization. This pathology in most cases leads to high mortality in both the antenatal and postnatal periods. The incidence of this disease ranges from 0.05 to 5%. Perinatal mortality in nonimmune hydrops fetalis accounts for about 80%, but with the manifestation of the disease in the early stages of pregnancy, the frequency of deaths is already about 95%. Most often, fetal death occurs due to severe heart failure and hypoxia. The most common causes of the development of nonimmune hydrops fetalis are: chromosomal abnormalities, pathology of the cardiovascular system and infectious diseases. Due to the emergence of a new coronavirus infection COVID-19, the question arises how the SARS-CoV-2 virus affects the course and outcome of pregnancy, as well as what effect it has on fetal development. And is it possible to assume that the SARS-CoV-2 virus can be attributed to the etiological factor of the occurrence of nonimmune hydrops fetalis. The article describes a clinical case of non-immune hydrops in a premature baby with a burdened obstetric and gynecological history against the background of COVID-19 during pregnancy, a severe course of the neonatal period. The review of current literature data on the pathogenesis, classification and features of clinical manifestations, diagnosis and treatment of such newborns is carried out.

1. Andreyev A.V., Kharlamova N.V., Mezhinskij S.S., Pesenkina A.A. Clinical case of non-immune hydrops in a preterm infant with paroxysmal tachycardia. Pediatrician (St. Petersburg). 2019;10(2):121-128. DOI: 10.17816/PED102121-128. EDN: RNZXWO

2. Kurtsev M.A., Gnetetskaya V.A., Mal’mberg O.L., Belkovskaya M.E., Lukash E.N., Shipulin G.A., Shipulina O.Yu., Tarasova Yu.A. et al. Nonimmune fetal dropsy: diagnosis and tactics. Obstetrics and gynecology. 2009;(2):37-40. EDN: KGWKSN

3. Kozlov P.V., Kuznetsov P.A., Leonova E.I., Konstantinova K.I. Nonimmune fetal hydrops. current approach to the etiology, pathogenesis and perinatal outcomes. Reproduction problems. 2014;(6):83-87. DOI: 10.17116/repro201420683-87. EDN: TKLYTV

4. Kadyrberdiyeva F.Z., Shmakov R.G., Bokeriya E.L., Tetruashvili N.K., Kostyukov K.V., Donnikov A.E., Belousov D.M. Nonimmune hydrops fetalis: main causes. Obstetrics and gynecology. 2019;(11):186-191. DOI: 10.18565/aig.2019.11.186-191. EDN: AAXMIR

5. Kuznetsov P.A., Kozlov P.V., Dzhokhadze L.S., Konstantinova K.I. Non-lmmune hydrops of one fetus from the twins: clinical observation. Bulletin of the Russian State Medical University. 2014;(4):42-44. EDN: UMXGWL

6. Tumanova U.N., Lyapin V.M., Bychenko V.G., Serova N.S., Shchegolev A.I. Postmortem MRI characteristics of nonimmune fetal hydrops.Russian electronic journal of radiology. 2018;8(4): 172-183. DOI: 10.21569/2222-7415-2018-8-2-172-183. EDN: VREWMY

7. Kadyrberdiyeva F.Z., Shmakov R.G., Bokeriya E.L. Nonimmune hydrops fetalis: modern principles of diagnosis and treatment. Obstetrics and gynecology. 2019;(10):28-34. DOI: 10.18565/aig.2019.10.28-34. EDN: FWQSEC

8. Kadyrberdiyeva F.Z., Tetruashvili N.K., Shmakov R.G., Bokeriya E.L., Kostyukov K.V., Kim L.V., Bystrykh O.A., Donnikov A.E. et al. Successful pregnancy outcome of nonimmune hydrops fetalis due to parvovirus B19. Obstetrics and gynecology. 2020;(3):238-244. DOI: 10.18565/aig.2020.3.238-244. EDN: SZHIYB

9. Kadyrberdiyeva F.Z., Shmakov R.G., Bokeriya E.L., Kostyukov K.V., Tetruashvili N.K. The effectiveness of the antenatal examination algorithm for nonimmune hydrops fetalis. Obstetrics and gynecology. 2020;(7):71-78. DOI: 10.18565/aig.2020.7.71-78. EDN: HTSCUO

10. Degtyarev D.N. Can SARS-CoV-2 virus be considered as a causative agent of TORCH infections in newborn babies? Neonatology: news, views, education. 2021;9(1):5-7. DOI: 10.33029/2308-2402-2021-9-1-5-7. EDN: HLVWOG

11. Kosolapova Yu.A., Morozov L.A., Inviyaeva E.V., Makieva M.I., Zubkov V.V., Degtyarev D.N. Impact of covid-19 on pregnancy outcomes and neonatal health (literature review). Obstetrics and gynecology. News. Views. Education. 2021;9(4):63-70. DOI: 10.33029/2303-9698-2021-9-4-63-70. EDN: XPKJJC

12. Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809-815. DOI: 10.1016/S0140-6736(20)30360-3.

13. Yan J., Guo J., Fan C., Juan J., Yu X., Li J., Feng L., Li C. et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol. 2020;223(1):111.e1-111.e14. DOI: 10.1016/j.ajog.2020.04.014

14. Ferrazzi E., Frigerio L., Savasi V., Vergani P., Prefumo F., Barresi S., Bianchi S., Ciriello E. et al. Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis. BJOG. 2020;127(9):1116-1121. DOI: 10.1111/1471-0528.16278

15. Dumitriu D., Emeruwa U.N., Hanft E., Liao G.V., Ludwig E., Walzer L., Arditi B., Saslaw M. et al. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City. JAMA Pediatr. 2021;175(2):157-167. DOI: 10.1001/jamapediatrics.2020.4298

16. Zeng L., Xia S., Yuan W., Yan K., Xiao F., Shao J., Zhou W. Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China. JAMA Pediatr. 2020;174(7): 722-725. DOI: 10.1001/jamapediatrics.2020.0878

17. Dong L., Tian J., He S., Zhu C., Wang J., Liu C., Yang J. Possible Vertical Transmission of SARS- CoV-2 From an Infected Mother to Her Newborn. JAMA. 2020;323(18):1846-1848. DOI: 10.1001/jama.2020.4621

18. Kirtsman M., Diambomba Y., Poutanen S.M., Malinowski A.K., Vlachodimitropoulou E., Parks W.T., Erdman L., Morris S.K. et al. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection. CMAJ. 2020;192(24):E647-E650. DOI: 10.1503/cmaj.200821

19. Demirjian A., Singh C., Tebruegge M., Herbert R., Draz N., Mirfenderesky M., Jones V., Hinstridge P. et al. Probable Vertical Transmission of SARS-CoV-2 Infection. Pediatr Infect Dis J. 2020;39(9):e257-e260. DOI: 10.1097/INF.0000000000002821

20. Sisman J., Jaleel M.A., Moreno W., Rajaram V., Collins R.R.J., Savani R.C., Rakheja D., Evans A.S.Intrauterine Transmission of SARS-COV-2 Infection in a Preterm Infant. Pediatr Infect Dis J. 2020;39(9): e265-e267. DOI: 10.1097/INF.0000000000002815

21. Lorenz N., Treptow A., Schmidt S., Hofmann R., Raumer-Engler M., Heubner G., Gröber K. Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms. Pediatr Infect Dis J. 2020;39(8):e212. DOI: 10.1097/INF.0000000000002735

22. Carvalho B.R., Adami K.S., Gonçalves-Ferri W.A., Samama M., Ferriani R.A., Marcolin A.C. COVID-19: Uncertainties from Conception to Birth. Rev Bras Ginecol Obstet. 2021;43(1):54-60. DOI: 10.1055/s-0040-1721856

23. la Cour Freiesleben N., Egerup P., Hviid K.V.R., Severinsen E.R., Kolte A.M., Westergaard D., Fich Olsen L., Prætorius L. et al. SARS-CoV-2 in first trimester pregnancy: a cohort study. Hum Reprod. 2021;36(1):40-47. DOI: 10.1093/humrep/deaa311

24. Zimmermann P., Curtis N. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features. Pediatr Infect Dis J. 2020;39(6):469-477. DOI: 10.1097/INF.0000000000002700

25. Baud D., Greub G., Favre G., Gengler C., Jaton K., Dubruc E., Pomar L. Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection. JAMA. 2020;323(21):2198-2200. DOI: 10.1001/jama.2020.7233

26. Verma S., Bradshaw C., Auyeung N.S.F., Lumba R., Farkas J.S., Sweeney N.B., Wachtel E.V., Bailey S.M. et al. Outcomes of Maternal-Newborn Dyads After Maternal SARS-CoV-2. Pediatrics. 2020;146(4):e2020005637. DOI: 10.1542/peds.2020-005637

27. Di Mascio D., Khalil A., Saccone G., Rizzo G., Buca D., Liberati M., Vecchiet J., Nappi L. et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2):100107. DOI: 10.1016/j.ajogmf.2020.100107

28. Society for Maternal-Fetal Medicine (SMFM), Norton M.E., Chauhan S.P., Dashe J.S. Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol. 2015;212(2):127-139. DOI: 10.1016/j.ajog.2014.12.018

29. He S., Wang L., Pan P., Wei H., Meng D., Du J., Tian X., Zheng C. et al. Etiology and Perinatal Outcome of Nonimmune Hydrops Fetalis in Southern China. AJP Rep. 2017;7(2):e111-e115. DOI: 10.1055/s-0037-1603890

30. Hartge D.R., Weichert J., Gembicki M., Krapp M. Confirmation of etiology in fetal hydrops by sonographic evaluation of fluid allocation patterns. Eur J Obstet Gynecol Reprod Biol. 2015;195:128-132. DOI: 10.1016/j.ejogrb.2015.09.006

31. Ng Z.M., Seet M.J., Erng M.N., Buendia F., Chang A.S., Sriram B. Nonimmune hydrops fetalis in a children's hospital: a six-year series. Singapore Med J. 2013;54(9):487-490. DOI: 10.11622/smedj.2013169

32. Fukushima K., Morokuma S., Fujita Y., Tsukimori K., Satoh S., Ochiai M., Hara T., Taguchi T. et al. Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis. Early Hum Dev. 2011;87(8):571-575. DOI: 10.1016/j.earlhumdev.2011.04.015